Literature DB >> 18381038

[Vaccination coverage against Streptococcus pneumoniae in splenectomized patients in a fourth-level hospital (1999-2004)].

Manuel Enrique Fuentes-Ferrer1, Sara Cano-Escudero, Gloria Mato-Chaín, Alberto Mariano-Lázaro, José Fereres-Castiel.   

Abstract

INTRODUCTION: Patients in whom the spleen has been removed have a higher risk of acquiring infection by capsulated microorganisms, particularly Streptococcus pneumoniae, Haemophilus influenzae type b, and Neisseria meningitidis. AIMS: Determine the vaccination coverage against S. pneumoniae of splenectomized patients in Hospital Clínico San Carlos (HCSC, Madrid) and to identify variables related to the level of vaccination coverage reached.
METHODS: From January 1, 1999 to December 31, 2004, a retrospective cohort study of all splenectomized patients was carried out in HCSC. Patients were identified from the Medical Records Department and the vaccination registry of the Preventive Medicine Service.
RESULTS: During the study period, 248 splenectomies were carried out. The median age was 61.0 years (interquartile range, 39.0-71.0). The most frequent reason for splenectomy was malignant gastrointestinal neoplasm (34.7%). Overall vaccination coverage against S. pneumoniae for the period studied was 48.4%. A significant increase in vaccination coverage per year was observed (P < .001). Multivariate analysis identified the following variables associated with a greater risk of not being vaccinated: male sex, patients proceeding from surgical services, and patients undergoing splenectomy during 1999 to 2001.
CONCLUSIONS: Vaccination coverage has increased every year since implementation of the protocol. Nevertheless, it necessary to extend the vaccination program within daily clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381038     DOI: 10.1016/s0213-005x(08)72690-9

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  2 in total

1.  Management of post-splenectomy patients in the Netherlands.

Authors:  A J J Lammers; D Veninga; M J M H Lombarts; J B L Hoekstra; P Speelman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-22       Impact factor: 3.267

2.  [Invasive pneumococcal infection prevention in asplenic patients].

Authors:  J Rodríguez-García; R Fernández-Santos; E Ruiz de Gopegui-Bordes; O Hidalgo-Pardo
Journal:  Rev Esp Quimioter       Date:  2020-01-03       Impact factor: 1.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.